CureVac's Grant

CureVac raised a round of funding on February 13, 2018. Investors include Bill & Melinda Gates Foundation.

CureVac, a German clinical stage biopharmaceutical company founded in 2000, is pioneering the field of mRNA-based technology platforms for medical purposes, in which unmodified mRNA is specifically op…

Articles about CureVac's Grant: